Corporate Governance


The Board of Directors of Complete Genomics sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance and oversight. It is the duty of the Board of Directors to serve as a prudent fiduciary for stockholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in the corporate governance guidelines available below. The Board of Directors has also adopted a Code of Business Conduct and Ethics that applies to all of the Company’s directors, officers and employees. In addition, each of the three standing committees operates under a written charter approved by the Board of Directors and in accordance with the rules and regulations of The NASDAQ Stock Market.

The guidelines, code of business conduct and committee charters are each subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Document View
Corporate Governance Guidelines PDF   39.9 KB Add to Briefcase
Code of Business Conduct and Ethics PDF   53.2 KB Add to Briefcase
Audit Committee Charter PDF   29.7 KB Add to Briefcase
Compensation Committee Charter PDF   96.0 KB Add to Briefcase
Nominating and Corporate Governance Committee Charter PDF   19.6 KB Add to Briefcase


Add to Briefcase = add file to Briefcase

Stock Quote
(NASDAQ: GNOM)

Price:
1.75
Change:
+ 0.06
Day High:
1.93
Day Low:
1.68
Volume:
937,900
4:00 PM ET on May 16, 2012
Delayed at least 20 minutes.
Provided by eSignal.

SHAREHOLDER TOOLS

Briefcase Printed Materials Email Alerts Download Center RSS

Copyright © 2012 Complete Genomics Incorporated. All rights reserved. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.